APA (7th ed.) Citation

Bodo, J., Duraj, J., Chovancova, J., Jakubikova, J., Sedlak, J., & Hunakova, L. Administration of isothiocyanate (E-4IB) and cisplatin leads to altered signalling and lysosomal export in human ovarian carcinoma sensitiveand cisplatin-resistant cells.

Chicago Style (17th ed.) Citation

Bodo, J., J. Duraj, J. Chovancova, J. Jakubikova, J. Sedlak, and L. Hunakova. Administration of Isothiocyanate (E-4IB) and Cisplatin Leads to Altered Signalling and Lysosomal Export in Human Ovarian Carcinoma Sensitiveand Cisplatin-resistant Cells.

MLA (9th ed.) Citation

Bodo, J., et al. Administration of Isothiocyanate (E-4IB) and Cisplatin Leads to Altered Signalling and Lysosomal Export in Human Ovarian Carcinoma Sensitiveand Cisplatin-resistant Cells.